Atyr Pharma Inc (ATYR)

Atyr Pharma Inc stock is traded at $6.22, with a volume of 21,777. It is up +3.15% in the last 24 hours and down -45.13% over the past month. aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).